Osman Manavoğlu

440 total citations
27 papers, 333 citations indexed

About

Osman Manavoğlu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Osman Manavoğlu has authored 27 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in Osman Manavoğlu's work include Lung Cancer Research Studies (7 papers), Neuroendocrine Tumor Research Advances (6 papers) and Advanced Breast Cancer Therapies (3 papers). Osman Manavoğlu is often cited by papers focused on Lung Cancer Research Studies (7 papers), Neuroendocrine Tumor Research Advances (6 papers) and Advanced Breast Cancer Therapies (3 papers). Osman Manavoğlu collaborates with scholars based in Türkiye. Osman Manavoğlu's co-authors include Türkkan Evrensel, Özkan Kanat, Ender Kurt, Mutlu Demiray, Güzin Gönüllü, İlker Ercan, Özlem Saraydaroğlu, Erdem Çubukçu, Engı̇n Ulukaya and Taner Korkmaz and has published in prestigious journals such as Journal of Clinical Oncology, Cytokine and International Journal of Clinical Practice.

In The Last Decade

Osman Manavoğlu

27 papers receiving 320 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Osman Manavoğlu 179 97 87 75 57 27 333
Jieli Han 165 0.9× 73 0.8× 102 1.2× 43 0.6× 74 1.3× 8 369
S. Nagel 239 1.3× 207 2.1× 76 0.9× 50 0.7× 27 0.5× 29 421
Daniel Duncan 97 0.5× 87 0.9× 78 0.9× 26 0.3× 67 1.2× 29 364
Kazumi Kuriwaki 95 0.5× 98 1.0× 127 1.5× 28 0.4× 25 0.4× 22 373
Kazunori Kamiya 119 0.7× 162 1.7× 114 1.3× 20 0.3× 34 0.6× 27 368
A. Michelotti 210 1.2× 100 1.0× 67 0.8× 37 0.5× 108 1.9× 15 372
Howard Liu 202 1.1× 198 2.0× 109 1.3× 71 0.9× 80 1.4× 43 555
Alessio Degiovanni 107 0.6× 85 0.9× 121 1.4× 44 0.6× 70 1.2× 23 345
M Izuo 175 1.0× 55 0.6× 50 0.6× 34 0.5× 103 1.8× 82 425

Countries citing papers authored by Osman Manavoğlu

Since Specialization
Citations

This map shows the geographic impact of Osman Manavoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osman Manavoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osman Manavoğlu more than expected).

Fields of papers citing papers by Osman Manavoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osman Manavoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osman Manavoğlu. The network helps show where Osman Manavoğlu may publish in the future.

Co-authorship network of co-authors of Osman Manavoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Osman Manavoğlu. A scholar is included among the top collaborators of Osman Manavoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osman Manavoğlu. Osman Manavoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanat, Özkan, et al.. (2014). Clinical significance of adiponectin expression in colon cancer patients. Journal of Cancer Research and Therapeutics. 10(2). 347–347. 9 indexed citations
2.
Çubukçu, Erdem, et al.. (2014). Lack of prognostic significance of adiponectin immunohistochemical expression in patients with triple-negative breast cancer. Współczesna Onkologia. 1(1). 34–38. 5 indexed citations
3.
Çubukçu, Erdem, Özkan Kanat, Ömer Fatih Ölmez, et al.. (2013). Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer.. PubMed. 18(2). 359–65. 5 indexed citations
4.
Bayrak, Muharrem, Ömer Fatih Ölmez, Ender Kurt, et al.. (2012). Prognostic significance of c-erbB2 overexpression in patients with metastatic gastric cancer. Clinical & Translational Oncology. 15(4). 307–312. 19 indexed citations
5.
Çubukçu, Erdem, et al.. (2011). Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: implications for patient outcome. Clinical & Translational Oncology. 13(11). 826–830. 4 indexed citations
6.
Kanat, Özkan, Taner Korkmaz, Erdem Çubukçu, et al.. (2011). Primary small cell carcinoma of the breast: Report of seven cases and review of the literature. Tumori Journal. 97(4). 473–478. 17 indexed citations
7.
Kömürcü, Şeref, Serdar Turhal, Kadri Altundağ, et al.. (2006). Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish oncology group trial. European Journal of Cancer Care. 16(1). 67–73. 8 indexed citations
8.
Demiray, Mutlu, Engı̇n Ulukaya, Özlem Saraydaroğlu, et al.. (2006). Response to Neoadjuvant Chemotherapy in Breast Cancer Could be Predictable by Measuring a Novel Serum Apoptosis Product, Caspase-Cleaved Cytokeratin 18: A Prospective Pilot Study. Cancer Investigation. 24(7). 669–676. 58 indexed citations
9.
Kanat, Özkan, Ender Kurt, Ulviye Yalçınkaya, Türkkan Evrensel, & Osman Manavoğlu. (2006). Comparison of uroprotective efficacy of mesna and amifostine in Cyclophosphamide- induced hemorrhagic cystitis in rats. Indian Journal of Cancer. 43(1). 12–12. 14 indexed citations
10.
11.
Kanat, Özkan, Türkkan Evrensel, Ender Kurt, et al.. (2005). 5-Fluorouracil, epirubicin and cisplatin in the treatment of metastatic gastric carcinoma: A retrospective analysis of 68 patients. Indian Journal of Cancer. 42(2). 85–85. 13 indexed citations
12.
Kurt, Ender, Canfeza Sezgin, Türkkan Evrensel, et al.. (2005). Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma. International Journal of Clinical Practice. 59(5). 537–543. 6 indexed citations
13.
Gönüllü, Güzin, Canan Ersoy, Türkkan Evrensel, et al.. (2005). Relation between insulin resistance and serum concentrations of IL-6 and TNF-α in overweight or obese women with early stage breast cancer. Cytokine. 31(4). 264–269. 21 indexed citations
14.
Kanat, Özkan, Şaduman Balaban Adım, Türkkan Evrensel, et al.. (2004). Prognostic Value of <I>nm23</I> in Gastrointestinal Stromal Tumors. Medical Oncology. 21(1). 53–58. 6 indexed citations
15.
Kurt, Ender, et al.. (2004). Induction chemotherapy and concomitant chemoradiotherapy (CRT) in patients with unresectable, locally advanced pancreatic carcinoma. Journal of Clinical Oncology. 22(14_suppl). 4164–4164. 1 indexed citations
16.
Evrensel, Türkkan, Ender Kurt, Mutlu Demiray, et al.. (2004). Comparison of Clinical Outcomes of Different Erythropoietin Usage Strategies. Tumori Journal. 90(4). 394–398. 4 indexed citations
17.
Kanat, Özkan, Türkkan Evrensel, Ender Kurt, et al.. (2004). Treatment of Metastatic Pancreatic Cancer with a Combination of Gemcitabine and 5-Fluorouracil: A Single Center Phase II Study. Tumori Journal. 90(2). 192–195. 6 indexed citations
18.
Kanat, Özkan, Türkkan Evrensel, İbrahim Baran, et al.. (2003). Protective Effect of Amifostine Against Toxicity of Paclitaxel and Carboplatin in Non-small Cell Lung Cancer: A Single Center Randomized Study. Medical Oncology. 20(3). 237–246. 36 indexed citations
19.
Yalçın, Şuayib, et al.. (1998). Successful treatment of cranial metastases of extrapulmonary small cell carcinoma with chemotherapy alone. Medical Oncology. 15(1). 66–69. 6 indexed citations
20.
Manavoğlu, Osman, et al.. (1996). Second primary cancer due to radiotherapy and chemotherapy.. PubMed. 15(2-4). 275–8. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jieli Han Breakdown of academic impact, for papers by S. Nagel Breakdown of academic impact, for papers by Daniel Duncan Breakdown of academic impact, for papers by Kazumi Kuriwaki Breakdown of academic impact, for papers by Kazunori Kamiya Breakdown of academic impact, for papers by A. Michelotti Breakdown of academic impact, for papers by Howard Liu Breakdown of academic impact, for papers by Alessio Degiovanni Breakdown of academic impact, for papers by M Izuo
Rankless by CCL
2026